Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $85...
Piper Sandler analyst Matt O'Brien reiterates PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price t...
Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price targe...
PROCEPT BioRobotics (NASDAQ:PRCT) sees FY2026 sales of $410.000 million-$430.000 million vs $427.376 million analyst estimate.
PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2025 sales outlook from $325.500 million to $325.500 million vs $326.566 million es...
PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $...
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price targe...
